Class II · Moderate risk
Endophth Kit
Lack of Assurance of Sterility
Is Ceftazidime recalled?
Yes — there is an active recall. 1 ongoing FDA recall mention Ceftazidime (12 total). Check the affected lots below.
Most common reason: Sterility / contamination (11 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Ceftazidime. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Ceftazidime recalls on record
none so far in 2026; 12 on record, newest first
Class II · Moderate risk
Ceftazidime Intravitreal
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Class II · Moderate risk
CEFTAZIDIME INTRAVITREAL 2.25MG/0.1ML Solution
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Class II · Moderate risk
Ceftazidime
Lack of Assurance of Sterility
Class I · High risk
Ceftazidime for Injection USP and Dextrose for Injection USP
Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.
Class II · Moderate risk
Ceftazidime Sterile Ophthalmic Solution for Injection Preservative Free 11.25mg / 0.5ml
Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.
Class II · Moderate risk
Ceftazidime
Lack of Assurance of Sterility
Class II · Moderate risk
Ceftazidime 2 gm / NS 50mL
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Ceftazidime various strength in normal saline bags
Lack of sterility assurance.
Class II · Moderate risk
Ceftazidime
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Class II · Moderate risk
Ceftazidime
Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.
Class II · Moderate risk
Ceftazidime Ophthalmic
Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.